Dergiler / Türkiye Çocuk Hastalıkları Dergisi / 2026 / Cilt: 14 Sayı: COVID-19

Covid 19 Enfeksiyonu Olan Hastalarda Koagülasyon Sistem Anormallikleri

Coagulation system abnormalities in patients with COVID-19 infection

Dilek Gürlek(Ankara Şehir Hastanesi, Çocuk Hastanesi, Çocuk Hematoloji Kliniği)0000-0001-8097-3950
Namık Yaşar Özbek(Ankara Şehir Hastanesi, Çocuk Hastanesi, çocuk Hematoloji Kliniği ANKARA)0000-0001-6857-0681
Sayfa
37–40
Yayın Tarihi
2020-07-24
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Ölüm oranı %4,3-14,6 arasında değişmekle birlikte, çalışmalar koagülasyon disfonksiyonunun ağır COVID-19 enfeksiyonu olan hastalarda önemli bir ölüm nedeni olduğunu ortaya koymuştur.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Çin'de Şiddetli Akut Solunum Yetmezliği Sendromu-Coronavirus-2'nin (SARS-CoV-2) neden olduğu COVID-19 enfeksiyonu tüm dünya çapında bir pandemiye yol açmıştır.
📊
Temel Bulgular & Veri:Ölüm oranı %4,3-14,6 arasında değişmekle birlikte, çalışmalar koagülasyon disfonksiyonunun ağır COVID-19 enfeksiyonu olan hastalarda önemli bir ölüm nedeni olduğunu ortaya koymuştur.
💡
Sonuç & Katkı:Bu yazıda COVID-19 enfeksiyonu olan hastalardaki koagülasyon sistemi bozuklukları tartışılmaktadır.
🔬Tür:Derleme
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:koagulopati · COVID-19 · coronavirus

Özet

Çin'de Şiddetli Akut Solunum Yetmezliği Sendromu-Coronavirus-2'nin (SARS-CoV-2) neden olduğu COVID-19 enfeksiyonu tüm dünya çapında bir pandemiye yol açmıştır. Ölüm oranı %4,3-14,6 arasında değişmekle birlikte, çalışmalar koagülasyon disfonksiyonunun ağır COVID-19 enfeksiyonu olan hastalarda önemli bir ölüm nedeni olduğunu ortaya koymuştur. Ağır hastaların çoğunda altta yatan bir hastalık (diyabet, kardiyovasküler hastalık, hipertansiyon) vardır ve başlangıçta solunum yetmezliği ortaya çıkar, ancak bazıları çoklu organ disfonksiyonuna neden olan sistemik hastalığa ilerler. Bu yazıda COVID-19 enfeksiyonu olan hastalardaki koagülasyon sistemi bozuklukları tartışılmaktadır.

Abstract

COVID-19 infection caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) in China led to a pandemic all over the world. Although mortality rate between 4.3% to 14.6%, studies have shown that coagulation dysfunction is a major cause of death in patients with severe COVID-19 infection. The majority of the severely ill patients have underlying disease (i.e. diabetes, cardiovascular disease, hypertension) and initially present with respiratory insufficiency but some of them progress to systemic disease causing multiple organ dysfunction. This manuscript reviews coagulation system abnormalities in patients with COVID-19 infection.

🔖

Bu Makaleye Atıf Yap

Gürlek, D., Özbek, N. Y. (2020). Covid 19 Enfeksiyonu Olan Hastalarda Koagülasyon Sistem Anormallikleri. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 14 Sayı: COVID-19, 37–40. https://doi.org/10.12956/tchd.757753

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (50)

  1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513
  2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506
  3. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844- 847
  4. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. Doi:10.1001/jamainternmed.2020.0994
  5. Fogarty H, Townsend L, Cheallaigh CN, et al. COVID-19 Coagulopathy in Caucasian patients. Br J Haematol 2020, doi.org/10.1111/bjh.16749
  6. Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39(5):517–28
  7. Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost 2018;16:231-41
  8. Iba T, Levy JH, Wada H, et al. Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH. J Thromb Haemost 2019;17:415-9
  9. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. 10.1001/jama.2020.1585
  10. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62
  11. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020. 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032
  12. Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 2020. doi: 10.1111/jth.14854
  13. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 doi: 10.1182/blood.2020006000
  14. Fox SE, Akmatbekov A, Harbert JL, Li G, et al. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. medRxiv 2020.04.06.20050575; doi:
  15. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020. 395(10234):1417-1418 doi: 10.1016/S0140-6736(20)30937-5
  16. Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020. doi: 10.1016/j.thromres.2020.04.013
  17. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020 doi:10.1111/jth.14830
  18. Song JC, Wang G, Zhang W, Zhang Y, et al. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res. 2020.20;7(1):19. doi: 10.1186/s40779-020-00247-7
  19. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-1026. doi: 10.1111/jth.14810
  20. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18(5):1094-1099. doi: 10.1111/jth.14817
  21. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID -19. Thromb Res, 2020. doi:
  22. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020. 23;191:9-14. doi: 10.1016/j.thromres.2020.04.024 23- Iba T, Arakawa M, Ohchi Y, et al. Prediction of Early Death in Patients With SepsisAssociated Coagulation Disorder Treated With Antithrombin Supplementation. Clin Appl Thromb Hemost 2018:1076029618797474
  23. Wang J, Hajizadeh N, Moore EE, McIntyre RC, et al. Tissue Plasminogen Activator (tPA) Treatment for COVID‐19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series. J Thromb Haemost. 2020 doi:10.1111/jth.14828
  24. Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, et al. Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-center study of 23 patients. BMC Anesthesiol. 2014;14:24
  25. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi. 12 Nisan 2020, 64-68
  26. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513
  27. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506
  28. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844- 847
  29. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. Doi:10.1001/jamainternmed.2020.0994
  30. Fogarty H, Townsend L, Cheallaigh CN, et al. COVID-19 Coagulopathy in Caucasian patients. Br J Haematol 2020, doi.org/10.1111/bjh.16749
  31. Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39(5):517–28
  32. Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost 2018;16:231-41
  33. Iba T, Levy JH, Wada H, et al. Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH. J Thromb Haemost 2019;17:415-9
  34. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. 10.1001/jama.2020.1585
  35. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62
  36. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020. 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032
  37. Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 2020. doi: 10.1111/jth.14854
  38. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 doi: 10.1182/blood.2020006000
  39. Fox SE, Akmatbekov A, Harbert JL, Li G, et al. Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans. medRxiv 2020.04.06.20050575; doi:
  40. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020. 395(10234):1417-1418 doi: 10.1016/S0140-6736(20)30937-5
  41. Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020. doi: 10.1016/j.thromres.2020.04.013
  42. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020 doi:10.1111/jth.14830
  43. Song JC, Wang G, Zhang W, Zhang Y, et al. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res. 2020.20;7(1):19. doi: 10.1186/s40779-020-00247-7
  44. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023-1026. doi: 10.1111/jth.14810
  45. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18(5):1094-1099. doi: 10.1111/jth.14817
  46. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID -19. Thromb Res, 2020. doi:
  47. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020. 23;191:9-14. doi: 10.1016/j.thromres.2020.04.024 23- Iba T, Arakawa M, Ohchi Y, et al. Prediction of Early Death in Patients With SepsisAssociated Coagulation Disorder Treated With Antithrombin Supplementation. Clin Appl Thromb Hemost 2018:1076029618797474
  48. Wang J, Hajizadeh N, Moore EE, McIntyre RC, et al. Tissue Plasminogen Activator (tPA) Treatment for COVID‐19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series. J Thromb Haemost. 2020 doi:10.1111/jth.14828
  49. Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, et al. Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-center study of 23 patients. BMC Anesthesiol. 2014;14:24
  50. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi. 12 Nisan 2020, 64-68.